Response to Letter Regarding Article, “Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial” | Zendy

William Whiteley | Zendy; Douglas Thompson | Zendy; Peter Sandercock | Zendy

Open Access

Response to Letter Regarding Article, “Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial”

Author(s) -

William Whiteley,

Douglas Thompson,

Peter Sandercock

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.114.005871

Subject(s) - medicine , thrombolysis , stroke (engine) , clinical trial , recombinant tissue plasminogen activator , tissue plasminogen activator , population , plasminogen activator , intracerebral hemorrhage , surgery , ischemic stroke , subarachnoid hemorrhage , ischemia , mechanical engineering , environmental health , myocardial infarction , modified rankin scale , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research